miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer
Authors
Keywords
Bladder cancer, miR-19a, PTEN, Circulation miRNA
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 33, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-08-09
DOI
10.1186/s13046-014-0067-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum miR-19a Predicts Resistance to FOLFOX Chemotherapy in Advanced Colorectal Cancer Cases
- (2014) Qi Chen et al. Asian Pacific Journal of Cancer Prevention
- Urine miRNA in nephrotic syndrome
- (2014) Cheuk-Chun Szeto CLINICA CHIMICA ACTA
- MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1
- (2014) Q Wu et al. Cell Death & Disease
- MicroRNA-16 Inhibits Bladder Cancer Proliferation by Targeting Cyclin D1
- (2013) Qi-Quan Jiang et al. Asian Pacific Journal of Cancer Prevention
- Urinary biomarkers of bladder cancer: an update and future perspectives
- (2013) Charles J Rosser et al. Biomarkers in Medicine
- Silencing of the miR-17 92 Cluster Family Inhibits Medulloblastoma Progression
- (2013) B. L. Murphy et al. CANCER RESEARCH
- microRNAs in liver disease: From diagnostics to therapeutics
- (2013) Kenji Takahashi et al. CLINICAL BIOCHEMISTRY
- miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling
- (2013) Yuwen Guo et al. FEBS Journal
- Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1
- (2013) Yonghua Han et al. FEBS LETTERS
- miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1
- (2013) Yiwei Lin et al. FEBS LETTERS
- Regulation of microRNAs by epigenetics and their interplay involved in cancer
- (2013) Xiaolan Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma
- (2013) Ming-Qi Fan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer
- (2013) Zishu Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer
- (2013) Qunying Lin et al. JOURNAL OF SURGICAL ONCOLOGY
- MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1
- (2013) Xianglai Xu et al. Journal of Translational Medicine
- Therapeutic Effects of MicroRNA-582-5p and -3p on the Inhibition of Bladder Cancer Progression
- (2013) Keita Uchino et al. MOLECULAR THERAPY
- MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer
- (2013) Shahana Majid et al. PLoS One
- HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b
- (2013) Ilaria Lepore et al. PLoS One
- MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia
- (2012) Huashan Ye et al. NUCLEIC ACIDS RESEARCH
- Plasma microRNA profiles for bladder cancer detection
- (2012) Liana Adam et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
- (2012) Anna-Regina Scheffer et al. WORLD JOURNAL OF UROLOGY
- miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma
- (2011) Lijuan Chen et al. CANCER LETTERS
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing
- (2011) Yonghua Han et al. PLoS One
- MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels
- (2011) Lena M. Wulfken et al. PLoS One
- Circulating microRNAs (miRNA) in Serum of Patients With Prostate Cancer
- (2011) Robert Mahn et al. UROLOGY
- miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer
- (2010) S. Yu et al. CANCER RESEARCH
- The miR-17-92 Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence
- (2010) L. Hong et al. CANCER RESEARCH
- Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
- (2010) Nobuyoshi Kosaka et al. CANCER SCIENCE
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer
- (2010) Zhibin Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma
- (2010) Changzheng Liu et al. JOURNAL OF HEPATOLOGY
- A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
- (2010) Hua Zhao et al. PLoS One
- Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
- (2009) J. W.F. Catto et al. CANCER RESEARCH
- miR-19 is a key oncogenic component of mir-17-92
- (2009) V. Olive et al. GENES & DEVELOPMENT
- Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
- (2008) Charles H. Lawrie et al. BRITISH JOURNAL OF HAEMATOLOGY
- Molecular pathogenesis of bladder cancer
- (2008) Margaret A. Knowles International Journal of Clinical Oncology
- MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia
- (2008) J. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search